Authorities Recognize a Need to Encourage Pediatric Drug Development

News

Article

Applied Clinical Trials

January 1, 2002

Applied Clinical Trials

Applied Clinical Trials-01-01-2002

Volume

Authorities Recognize a Need to Encourage Pediatric Drug Development

Addressing the unnacceptable lack of pediatric labeling requires not only economic incentives but also an understanding of the unique difficulties involved in pediatric studies.

Articles in this issue

IRB Accreditation and Human Subject Protection

Europe Looks at Trials in Future Research

Clinical Research to Remain in the Spotlight This Year

Authorities Recognize a Need to Encourage Pediatric Drug Development

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Authorities Recognize a Need to Encourage Pediatric Drug Development

Newsletter